In this paper, we show that the expression of oncogenic β-catenin and activation of the WNT pathway in Hesx1+ embryonic pituitary precursors or Sox2+ pituitary stem cells in young mice results in the activation of a robust SASP in targeted cells and the subsequent paracrine formation of tumours. The gene discussed is SOX2; the disease is neoplasm.